Insight Molecular Diagnostics (IMDX) Prepaid Assets: 2020-2025
Historic Prepaid Assets for Insight Molecular Diagnostics (IMDX) over the last 6 years, with Sep 2025 value amounting to $1.2 million.
- Insight Molecular Diagnostics' Prepaid Assets rose 97.61% to $1.2 million in Q3 2025 from the same period last year, while for Sep 2025 it was $1.2 million, marking a year-over-year increase of 97.61%. This contributed to the annual value of $821,000 for FY2024, which is 27.68% up from last year.
- Insight Molecular Diagnostics' Prepaid Assets amounted to $1.2 million in Q3 2025, which was down 8.22% from $1.4 million recorded in Q2 2025.
- Insight Molecular Diagnostics' 5-year Prepaid Assets high stood at $2.3 million for Q1 2021, and its period low was $595,000 during Q2 2024.
- Its 3-year average for Prepaid Assets is $909,600, with a median of $778,000 in 2024.
- In the last 5 years, Insight Molecular Diagnostics' Prepaid Assets soared by 140.92% in 2021 and then crashed by 69.09% in 2023.
- Over the past 5 years, Insight Molecular Diagnostics' Prepaid Assets (Quarterly) stood at $901,000 in 2021, then rose by 8.44% to $977,000 in 2022, then slumped by 34.19% to $643,000 in 2023, then increased by 27.68% to $821,000 in 2024, then surged by 97.61% to $1.2 million in 2025.
- Its Prepaid Assets was $1.2 million in Q3 2025, compared to $1.4 million in Q2 2025 and $1.2 million in Q1 2025.